Health Bulletin 01/October/2025

Private hospitals in the state have taken their fight against the new bio-medical waste fee system to the Telangana High Court. The petitioners alleged that the system unfairly penalises bedded facilities while non-bedded institutions pay strictly in proportion to the waste they generate.

While hearing the matter, a division bench comprising Justices Abhinand Kumar Shavili and Vakiti Ramakrishna Reddy directed the state and central governments, along with the Telangana Pollution Control Board (TGPCB) and the Central Pollution Control Board, to respond to the plea filed by private hospitals and doctors’ bodies regarding bio-medical waste charges.

For more details, check out the full story on the link mentioned below:

Telangana HC issues notice on hospitals' plea over biomedical waste fee

Over 3.6 crore people screened for Non-Communicable diseases under health campaign: JP Nadda

Union Health Minister JP Nadda on Monday informed that nine lakh health camps have been held across the country under the 'Swasth Nari, Sashakt Parivar Abhiyaan. These camps have screened over 3.6 crore people for non-communicable diseases, such as hypertension, diabetes, and cancers.

Speaking at a media event in the national capital, Nadda noted that the health camps have screened over 3.6 crore people for non-communicable diseases, such as hypertension, diabetes, and cancers.

For more details, check out the full story on the link mentioned below:

Over 3.6 crore people screened for non-communicable diseases, says JP Nadda

AIIMS blacklists supplier over fungal contamination in injectables for brain swelling, eye BP

A major safety lapse occurred at the All India Institute of Medical Sciences (AIIMS), where fungus was found in batches of crucial medical supplies, including injectables used for brain swelling, eye pressure, and intravenous fluids, according to a recent report by The New Indian Express. Following this, AIIMS terminated its contract with Pentagon Labs Limited and barred the supplier from bidding for tenders for the next two years. AIIMS had entered into a two-year agreement with Pentagon Labs in May 2024 for the supply of crystalloid solutions.

The contract came under scrutiny after multiple departments reported fungal contamination in the injectables used to treat cerebral edema, ocular hypertension, and dehydration. Despite a formal complaint in July demanding replacement of 4,800 contaminated bottles, the supplier failed to respond or take corrective action. AIIMS’s investigation confirmed repeated supply of substandard products, risking patient safety and disrupting medical services. Citing gross misconduct and violation of contract and procurement rules, AIIMS banned Pentagon Labs immediately and procured alternative supplies to ensure uninterrupted patient care.